Elekta AB 

SEK52.03
77
-SEK0.97-1.84% Friday 15:24

Statistics

Day High
52.3
Day Low
52.03
52W High
63.25
52W Low
42.3
Volume
710
Avg. Volume
-
Mkt Cap
19.18B
P/E Ratio
-
Dividend Yield
4.6%
Dividend
2.39

Upcoming

Dividends

4.6%Dividend Yield
Sep 26
SEK1.20
Mar 26
SEK1.20
Sep 25
SEK1.20
Mar 25
SEK1.20
Sep 24
SEK1.20
10Y Growth
15.86%
5Y Growth
15.18%
3Y Growth
4.71%
1Y Growth
9.77%

Earnings

25NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
0.03
0.07
0.11
0.16
Expected EPS
0.089186832
Actual EPS
N/A

Financials

-3.1%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
16.72BRevenue
-519MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0O5H.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap120.46B
Medtronic competes with Elekta in the neurosurgical market, offering products for brain surgeries and pain management that overlap with Elekta's Gamma Knife radiosurgery systems.
Intuitive Surgical
ISRG
Mkt Cap129.55B
Intuitive Surgical competes in the surgical space with robotic systems that, while not directly radiation therapy, offer alternative treatments for conditions Elekta's products also address.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific competes in the medical device market, particularly in neuromodulation, where its products can be seen as alternatives to Elekta's for certain conditions.
Smith & Nephew
SNN
Mkt Cap12.12B
Smith & Nephew competes in the advanced wound management and surgical devices market, indirectly competing with Elekta's offerings in surgical and oncology care.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet competes in the musculoskeletal healthcare market, including surgical solutions that can indirectly compete with Elekta's products for certain therapeutic and diagnostic applications.
Stryker
SYK
Mkt Cap126.84B
Stryker competes across several medical device markets, including neurotechnology and spine, where its products can compete with Elekta's neurosurgical and radiosurgery offerings.
Globus Medical
GMED
Mkt Cap11.14B
Globus Medical competes in the spine and neurosurgery markets with products that can be alternatives to Elekta's solutions for spinal and brain conditions.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie, through its acquisition of Allergan, competes in the neuroscience space, offering pharmaceutical alternatives to Elekta's device-based treatments for neurological conditions.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson, through its medical devices division, competes in several areas including surgery and oncology, offering products that can be seen as alternatives to Elekta's radiation therapy and neurosurgery devices.

About

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear machines and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo, a CT-Linac solution; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit, a gamma knife system; and Elekta Care, a personalized services for radiotherapy suites. In addition, the company offers brachytherapy products, including Elekta Studio, an image-guided brachytherapy solution; ImagingRing for dynamic imaging; Oncentra Brachy, a smart tool that facilitates repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Elekta Geneva, an applicator for cervical cancer patients; and Elekta Xoft Axxent electronic brachytherapy systems. Further, it provides Leksell Vantage Stereotactic System, a neurosurgery product; Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. Additionally, the company offers Elekta Care 360, which provides a range of clinical and professional services; Elekta Care Learning; Elekta Care Community, a self-help center; and Elekta Partner Community, an online self-service portal. Elekta AB (publ) was incorporated in 1972 and is headquartered in Stockholm, Sweden.
Show more...
CEO
Jakob Just-Bomholt
Employees
4102
Country
Sweden
ISIN
SE0000163628
WKN
000896279

Listings

0 Comments

Share your thoughts

FAQ

What is Elekta AB stock price today?
The current price of 0O5H.LSE is SEK52.03 SEK — it has decreased by -1.84% in the past 24 hours. Watch Elekta AB stock price performance more closely on the chart.
What is Elekta AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on London Exchange exchange Elekta AB stocks are traded under the ticker 0O5H.LSE.
Is Elekta AB stock price growing?
0O5H.LSE stock has fallen by -4.63% compared to the previous week, the month change is a +3.22% rise, over the last year Elekta AB has showed a +17.44% increase.
What is Elekta AB market cap?
Today Elekta AB has the market capitalization of 19.18B
When is the next Elekta AB earnings date?
Elekta AB is going to release the next earnings report on November 25, 2026.
What were Elekta AB earnings last quarter?
0O5H.LSE earnings for the last quarter are 0.69 SEK per share, whereas the estimation was 0.46 SEK resulting in a +47.97% surprise. The estimated earnings for the next quarter are N/A SEK per share.
What is Elekta AB revenue for the last year?
Elekta AB revenue for the last year amounts to 16.72B SEK.
What is Elekta AB net income for the last year?
0O5H.LSE net income for the last year is -519M SEK.
Does Elekta AB pay dividends?
Yes, 0O5H.LSE dividends are paid semi-annual. The last dividend per share was 1.2 SEK. As of today, Dividend Yield (FWD)% is 4.6%.
How many employees does Elekta AB have?
As of September 07, 2026, the company has 4,102 employees.
In which sector is Elekta AB located?
Elekta AB operates in the Health & Wellness sector.
When did Elekta AB complete a stock split?
The last stock split for Elekta AB was on September 12, 2012 with a ratio of 4:1.
Where is Elekta AB headquartered?
Elekta AB is headquartered in Stockholm, Sweden.